Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XOPENEX HFA® safely and effectively. See full prescribing information for XOPENEX HFA®.XOPENEX HFA® (levalbuterol tartrate) inhalation aerosol, for oral inhalation useInitial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
XOPENEX HFA is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.
- generic_name
- levalbuterol tartrate
- product_names
- levalbuterol tartrate
- ndc
- 27437-056, 27437-056-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en